Aurinia Pharmaceuticals
AUPH
#4833
Rank
NZ$3.36 B
Marketcap
NZ$26.16
Share price
-3.54%
Change (1 day)
90.83%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): NZ$0.23 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.29 Billion. In 2025 the company made an earning of NZ$0.20 Billion, an increase over its 2024 earnings that were of NZ$21.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.23 B16.71%
2025 NZ$0.20 B864.64%
2024 NZ$21.02 M-116.44%
2023 -NZ$0.13 Billion-31.8%
2022 -NZ$0.19 Billion-39.4%
2021 -NZ$0.31 Billion61.9%
2020 -NZ$0.2 Billion-9.73%
2019 -NZ$0.22 Billion92.65%
2018 -NZ$0.11 Billion36.39%
2017 -NZ$80.58 Million106.29%
2016 -NZ$39.06 Million-15.4%
2015 -NZ$46.17 Million65.84%
2014 -NZ$27.84 Million129.82%
2013 -NZ$12.12 Million-26.6%
2012 -NZ$16.51 Million
2010 -NZ$9.35 Million-39.22%
2009 -NZ$15.38 Million-43.78%
2008 -NZ$27.35 Million-53.19%
2007 -NZ$58.42 Million42.97%
2006 -NZ$40.87 Million-23.03%
2005 -NZ$53.1 Million36.1%
2004 -NZ$39.02 Million172.57%
2003 -NZ$14.32 Million484.61%
2002 -NZ$2.45 Million
2000 -NZ$11.63 Million453.81%
1999 -NZ$2.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$8.82 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-NZ$37.88 Million-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-NZ$9.4 Million-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA